Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

118 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

AMC-070 Interventions Form (RK5)

- 20.09.21 - 1 Formular, 3 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Header - Interventions Form, Interventions, Comments
AMC-070 Interventions Form (RK5) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E37C30-3E56-3E5F-E040-BB89AD43368B

AMC-063 Interventions Form (RK5)

- 20.09.21 - 1 Formular, 3 Itemgruppen, 16 Datenelemente, 1 Sprache
Itemgruppen: Header - Interventions Form, Interventions, Comments
AMC-063 Interventions Form (RK5) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8163A333-B8CA-35E0-E040-BB89AD435080

Nonneoplastic Condition NCT01057121 Demographic - AMC-070 Demographic Form (DEM) - 3146420v1.0 - AMC-070 Demographic Form (DEM)

- 20.09.21 - 1 Formular, 1 Itemgruppe, 7 Datenelemente, 1 Sprache
Itemgruppe: Demographics
AMC-070 Demographic Form (DEM) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E333A1-42F8-701C-E040-BB89AD433C30

Sarcoma NCT01016730 Demographic - AMC-063 Demographic Form (DEM) - 3020351v1.0 - AMC-063 Demographic Form (DEM)

- 17.09.21 - 1 Formular, 1 Itemgruppe, 7 Datenelemente, 1 Sprache
Itemgruppe: Demographics
AMC-063 Demographic Form (DEM) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=81639FFD-CB0E-371A-E040-BB89AD435082

Sarcoma NCT00450320 Demographic - AMC-051 Demographic Form (DEM) - 2636010v1.0 - AMC-051 Demographic Form (DEM)

- 17.09.21 - 1 Formular, 1 Itemgruppe, 7 Datenelemente, 1 Sprache
Itemgruppe: Header
AMC-051 Demographic Form (DEM) Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2FDFA89A-0726-6018-E044-0003BA3F9857

AMC-070 Off-Study Summary Form (F50)

- 09.10.17 - 1 Formular, 1 Itemgruppe, 4 Datenelemente, 1 Sprache
Itemgruppe: Off-Study Summary
AMC-070 Off-Study Summary Form (F50) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E448E8-A18B-E89F-E040-BB89AD433766

AMC-051 HIV Viral Load Form (F51)

- 09.10.17 - 1 Formular, 3 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV Viral Load Form, HIV Viral Load, Comments
AMC-051 HIV Viral Load Form (F51) Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=2FDFA89A-080D-6018-E044-0003BA3F9857

AMC-063 HIV T-Cell Laboratory Values Form (F63)

- 09.10.17 - 1 Formular, 3 Itemgruppen, 11 Datenelemente, 1 Sprache
Itemgruppen: Header - HIV T-Cell Laboratory Values Form, T-Cell Laboratory Values, Comments
AMC-063 HIV T-Cell Laboratory Values Form (F63) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=815FD9FC-242E-4365-E040-BB89AD437E9F

AMC-070 Overall Assessment Form (RK6)

- 09.10.17 - 1 Formular, 4 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Header - Overall Assessment Form, Overall Assessment, Disease Response, Comments
AMC-070 Overall Assessment Form (RK6) Lenalidomide in Treating Patients With AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=91E4BBD6-693F-9CA4-E040-BB89AD437D79

AMC-063 Physical Exam Form (RK2)

- 09.10.17 - 1 Formular, 4 Itemgruppen, 17 Datenelemente, 1 Sprache
Itemgruppen: Header - Physical Exam Form, Evaluation of Cutaneous Lesions, Evaluation of Marker Lesions, Comments
AMC-063 Physical Exam Form (RK2) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8163A333-BC0C-35E0-E040-BB89AD435080

AMC-063 FACT/GOG-Neurotoxicity Questionnaire Form (NTQ)

- 09.10.17 - 1 Formular, 3 Itemgruppen, 13 Datenelemente, 1 Sprache
Itemgruppen: Neurotoxicity Questionnaire Form, Neurotoxicity Questionnaire Form, Comments
AMC-063 FACT/GOG-Neurotoxicity Questionnaire Form (NTQ) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=816407E2-1423-1A8A-E040-BB89AD433DA9

AMC-063 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F37)

- 09.10.17 - 1 Formular, 4 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: Header - AIDS and Cancer Specimen Resource (ACSR) Procurement Form, Specimen Procurement, Contact Information, Comments
AMC-063 AIDS and Cancer Specimen Resource (ACSR) Procurement Form (F63) Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=815F9798-9F3D-E20D-E040-BB89AD435094

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video